<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,105.718,109.454,112.331,118.472,122.208,125.085,129.428,136.899,142.264,144.281,148.588,153.49,157.614,160.491,163.367,165.384,169.677,175.041,177.058,181.412,185.148,187.554,190.819,196.572,200.308,203.185,205.591,209.926,214.439,216.456,220.755,225.268,229.392,231.798,234.675,238.41,241.676,244.167,246.184,250.309,254.045,258.339,261.216,265.34,271.482,277.624,281.36,284.236,287.972,292.296,295.172,297.578,301.314,303.72,305.737,308.614,311.02,313.037,316.302,319.17900000000003,323.587,325.993" y="37.76400000000001" svg_rhmargin="330.117" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[24] Parmar MK, Torri V, Stewart L. Extracting summary statistics to</text>
  <text x="101.594,105.718,108.983,111.86,114.266,118.39,121.267,127.40899999999999,129.201,135.343,138.608,141.014,144.75,147.156,150.892,155.016,158.752,160.769,164.505,167.382,170.753,173.63,175.402,179.527,181.933,183.679,186.085,190.209,193.474,195.3,199.425,203.549,207.674,209.691,211.708,214.585,218.71,221.975,226.1,227.896,229.913,231.931,234.337,237.602,240.479,244.215,246.62,250.745,253.622,256.887,258.734,261.14,265.265,268.142,269.903,272.779,276.904,279.78,283.516,285.534,289.269,293.005,295.022,296.829,300.095,304.219,308.343,312.468,316.592,318.61,322.734,325.14,328.017" y="46.721000000000004" svg_rhmargin="330.034" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">perform meta-analyses of the published literature for survival endpoints.</text>
  <text x="101.594,105.33,107.737,111.474,113.88000000000001,116.391,123.864,127.13,131.255,133.74,137.865,141.991,146.116,150.241,152.259,156.384,160.509,162.599,166.725,170.85,174.975" y="55.678" svg_rhmargin="179.099" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Stat Med 1998;17:2815</text>
  <text x="179.093" y="55.678" svg_rhmargin="182.829" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="182.834,186.959,191.083" y="55.678" svg_rhmargin="193.1" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="85.21,87.616,91.741,95.865,98.271,101.594,106.958,111.083,114.348,118.472,121.349,125.085,129.20999999999998,131.015,138.486,144.24,146.257,148.078,152.979,157.104,160.369,162.194,165.459,169.583,175.725,179.849,181.867,185.991,189.727,192.133,194.15,198.275,202.4,204.256,208.381,210.787,212.589,215.855,218.731,221.137,223.155,229.296,233.032,235.438,238.703,241.58,243.428,245.834,248.71,252.835,258.97700000000003,260.775,264.899,266.917,269.323,271.729,274.994,277.871,281.136,285.26,287.666,289.516,292.781,296.906,301.03,304.295,307.172,309.189,315.331,318.596,322.721,325.127,328.003" y="64.63599999999997" svg_rhmargin="330.02" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[25] Cochran WG. The combination of estimates from different experiments.</text>
  <text x="101.594,106.107,108.125,112.249,118.391,121.656,124.062,126.939,128.956,132.221,135.098,137.648,141.772,145.897,150.021,154.146,156.163,160.288,164.412,166.429,170.554,174.678" y="73.59299999999996" svg_rhmargin="178.802" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Biometrics 1954;10:101</text>
  <text x="178.866" y="73.59299999999996" svg_rhmargin="182.602" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="182.608,186.733,190.858" y="73.59299999999996" svg_rhmargin="192.875" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">29.</text>
  <text x="85.21,87.616,91.741,95.865,98.271,101.594,107.818,109.836,113.572,117.308,119.325,123.449,126.326,128.861,131.738,135.862,137.879,140.426,145.328,149.452,153.576,159.718,163.843,166.719,170.924,175.049,177.557,181.293,187.046,189.063,191.616,197.37,200.635,203.9,208.025,210.90200000000002,213.442,216.319,219.195,221.212,223.76,227.025,229.431,231.98,235.716,237.734,239.751,242.298,249.77,253.035,256.771,259.648,263.84,266.717,268.734,272.858,276.594,279.146,281.163,285.288,288.553,292.677,296.802,299.678,301.696,304.572,306.978,310.244,314.368,317.633,321.36899999999997,323.93,325.947" y="82.54999999999995" svg_rhmargin="330.071" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in</text>
  <text x="101.594,107.736,111.001,113.407,117.143,119.549,123.285,127.409,131.145,133.163,136.899,139.775,143.04,145.917,147.934,150.516,155.029,162.501,165.37800000000001,167.862,171.987,176.111,180.236,184.36,186.378,190.502,194.626,198.751,200.768,204.893,209.017" y="91.56399999999996" svg_rhmargin="213.141" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">meta-analyses. BMJ 2003;327:557</text>
  <text x="213.222" y="91.56399999999996" svg_rhmargin="216.958" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="216.964,221.089,225.213" y="91.56399999999996" svg_rhmargin="227.23" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">60.</text>
  <text x="85.211,87.617,91.741,95.866,98.272,101.594,109.134,112.933,117.128,119.534,122.911,124.928,129.034,135.27,137.287,141.393,147.686,151.484,154.749,158.967,161.916,165.261,168.606,170.623,174.729,182.269,184.286,188.392,192.191,194.597,198.427,200.921,203.019,205.967,208.373,210.503,213.848,217.646,219.66299999999998,223.769,227.568,230.516,234.712,237.977,241.345,243.839,246.716,250.813,255.008,257.414,261.528,263.934,268.161,271.426,275.531,279.33,283.525,287.324,289.421,293.22,296.168,298.266,301.14300000000003,305.239,309.434,311.84000000000003,315.898,320.093,323.892,326.386" y="100.52099999999996" svg_rhmargin="330.122" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[27] Mantel N, Haenszel W. Statistical aspects of the analysis of data</text>
  <text x="101.595,104.001,106.981,111.181,117.323,121.386,124.339,127.681,130.163,133.039,137.24,140.193,144.394,147.735,151.076,153.482,155.612,159.41,162.67499999999998,166.724,169.672,172.154,176.355,180.556,182.649,185.914,188.791,192.91,197.111,199.517,203.574,207.775,209.792,212.745,216.086,219.898,222.851,226.193,228.21,232.259,235.136,239.176,245.412,249.224,251.706,253.72299999999998,257.772,263.215,267.027,271.227,274.493,277.86,280.737,284.834,287.239,291.44,294.393,296.799,300.856,305.057,309.257,313.458,317.659,319.676,323.877,328.077" y="109.47799999999995" svg_rhmargin="330.094" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">from retrospective studies of disease. J Natl Cancer Inst 1959;22:</text>
  <text x="101.595,105.79,109.916" y="118.43600000000004" svg_rhmargin="114.04" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">719</text>
  <text x="114.124" y="118.43600000000004" svg_rhmargin="117.86" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="117.922,122.118,126.313" y="118.43600000000004" svg_rhmargin="128.33" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">48.</text>
  <text x="85.211,87.617,91.741,95.866,98.272,101.594,107.348,110.614,113.49,117.226,119.243,125.385,129.51,133.634,135.652,139.387,143.512,146.208,151.573,153.59,156.299,160.812,164.548,166.565,169.442,173.567,176.197,182.339,184.356,187.025,194.496,197.762,200.168,203.974,206.38,210.116,214.241,217.977,219.994,223.73,226.606,228.624,231.501,234.19,236.207,240.332,242.976,246.242,248.259,250.276,254.401,256.418,259.683,263.419,265.436,268.146,270.552,273.429,275.446,279.182,281.199,284.076,286.093,288.838,294.202,298.327,302.451,304.857,307.734,311.858,313.875,316.558,321.923,323.94,325.958" y="127.39300000000003" svg_rhmargin="330.082" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[28] DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin</text>
  <text x="101.595,106.497,109.373,111.391,115.126,117.144,120.021,122.513,126.638,130.762,134.886,139.011,141.028,145.153,147.17,151.368,155.492" y="136.35000000000002" svg_rhmargin="159.616" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Trials 1986;7:177</text>
  <text x="159.592" y="136.35000000000002" svg_rhmargin="163.328" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="163.334,167.459,171.584" y="136.35000000000002" svg_rhmargin="173.601" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">88.</text>
  <text x="85.212,87.618,91.742,95.866,98.272,101.595,106.109,109.845,113.581,116.846,119.723,123.195,130.666,132.683,136.177,141.93,145.666,149.402,152.667,156.403,159.873,163.609,169.751,171.768,174.174,178.299,181.812,187.565,189.582,193.036,196.772,200.038,204.162,208.286,211.552,213.569,217.693,220.959,223.836,227.333,234.805,236.822,240.315,243.58,245.98600000000002,249.443,253.178,255.196,257.213,260.724,265.236,267.254,270.99,273.867,277.333,279.351,283.476,286.971,293.113,296.378,298.784,302.52,304.926,308.662,312.786,316.522,318.54,322.275,325.152,327.169" y="145.36400000000003" svg_rhmargin="330.046" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[29] Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis</text>
  <text x="101.596,105.72,108.985,111.391,114.657,117.922,120.328,123.593,127.718,130.223,134.348,138.084,140.598,144.334,146.834,149.71,151.728,157.87,161.994,164.012,167.277,169.29399999999998,171.834,175.57,178.446,182.182,186.307,190.431,192.448,195.714,199.45,201.46699999999998,204.033,206.439,209.704,212.58,214.986,217.003,219.509,224.022,231.494,234.371,236.856,240.98,245.104,249.229,253.353,255.449,259.574,263.698,267.822,269.84,273.964,278.089" y="154.32100000000003" svg_rhmargin="282.213" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">detected by a simple, graphical test. BMJ 1997;315:629</text>
  <text x="282.218" y="154.32100000000003" svg_rhmargin="285.954" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="285.96,290.085,294.211" y="154.32100000000003" svg_rhmargin="296.228" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="85.212,87.618,91.742,95.866,98.272,101.595,106.109,108.126,112.251,115.516,118.392,122.128,124.534,126.551,129.77,135.135,137.152,140.314,145.679,147.696,150.177,156.32,160.056,164.181,167.355,173.108,178.862,180.879,184.079,188.98,192.245,194.651,197.916,199.934,203.67,206.076,208.482,211.742,214.619,216.636,219.792,223.057,225.463,228.693,232.429,234.446,236.463,239.634,244.535,248.66,251.92499999999998,255.11,259.234,264.599,267.005,270.741,278.213,283.57800000000003,286.799,289.675,292.081,295.817,298.223,301.488,307.63,310.895,315.02,317.426,320.698,323.104,327.228" y="163.27800000000002" svg_rhmargin="330.105" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[30] Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for</text>
  <text x="101.596,104.472,107.738,111.862,115.987,118.863,121.269,123.286,127.411,131.147,133.512,136.388,140.124,143.001,145.407,148.672,154.814,158.55,160.956,162.973,166.238,168.601,171.478,174.743,178.479,180.497,183.762,189.515,192.392,194.792,198.528,202.652,206.777,209.078,215.22,218.485,220.891,224.627,227.032,230.768,234.984,238.72,240.737,244.473,247.35,250.615,253.49200000000002,255.845,259.97,262.37600000000003,264.689,267.565,269.971,274.096,278.22,280.238,283.503,286.38,288.782,291.188,295.312,299.048,301.454,303.748,307.013,310.749,314.485,316.502,320.697,324.433,326.839" y="172.236" svg_rhmargin="330.104" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">reporting systematic reviews and meta-analyses of studies that evaluate</text>
  <text x="101.596,105.72,108.985,112.721,114.739,117.145,121.27,123.138,126.403,130.139,133.016,136.28099999999998,138.161,140.178,144.302,146.708,149.974,152.85,156.586,159.851,163.976,166.382,168.399,172.523,176.648,179.524,181.541,183.511,186.776,190.9,195.025,197.042,200.778,204.902,208.638,211.044,213.062,217.186,221.311,223.193,226.929,231.053,235.178,237.081,240.346,242.364,246.1,250.224,254.349,257.225,260.961,263.367,265.384,269.509,273.633,275.65,277.557,280.434,282.262,287.628,289.645,291.663,295.788,297.683,302.196,306.32,308.338,312.462,315.727,321.945,323.963,328.087" y="181.19299999999998" svg_rhmargin="330.104" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">health care interventions: explanation and elaboration. J Clin Epidemiol</text>
  <text x="101.596,105.721,109.846,113.971,118.097,120.115,124.24,128.365,130.383,133.649" y="190.14999999999998" svg_rhmargin="137.773" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2009;62:e1</text>
  <text x="137.822" y="190.14999999999998" svg_rhmargin="141.558" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="141.564,145.689,149.814" y="190.14999999999998" svg_rhmargin="151.831" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="85.212,87.618,91.742,95.866,98.272,101.595,106.109,108.126,111.862,115.987,119.723,124.102,126.978,128.995,133.342,138.708,142.443,146.568,150.304,154.658,160.023,165.388,167.405,171.778,176.291,180.416,184.54,187.417,190.682,193.559,196.435,198.535,202.659,206.784,209.661,214.011,218.136,220.542,224.896,231.039,234.775,237.181,240.057,242.075,246.2,250.577,256.719,259.984,262.39,266.126,268.143,270.16,274.285,278.409,281.286,285.41,287.816,291.081,293.206,297.33,301.066,303.943,307.208,309.614,313.739,318.092,321.828,325.952" y="199.10699999999997" svg_rhmargin="330.076" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[31] Liang J, Yang YY. Expressions of matrix metalloproteinase-9 and</text>
  <text x="101.596,105.332,109.068,111.944,115.209,119.334,121.351,125.087,127.964,130.563,133.828,137.953,142.077,146.202,148.608,152.732,155.997,158.015,160.032,163.768,165.785,168.431,172.167,175.044,179.168,184.921,187.327,191.452,194.054,196.46,200.196,203.461,205.867,209.992,212.869,215.483,217.5,221.625,224.213,226.619,230.744,234.009,236.628,239.505,242.77,245.176,247.194,251.318,255.442,259.567,261.584,265.32,268.197,270.603,274.727,280.869,284.605,286.622,289.291,294.193,298.318,304.46,308.584,311.461,314.065,318.578,322.314,325.19,327.208" y="208.12099999999998" svg_rhmargin="330.085" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">vascular endothelial growth factor in the retinoblastoma. Tumor Basis</text>
  <text x="101.596,106.961,108.978,110.995,115.12,117.639,121.764,125.888,130.013,134.137,136.154,140.279,144.403,146.421,150.545" y="217.07799999999997" svg_rhmargin="154.669" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Clin 2017;30:27</text>
  <text x="154.717" y="217.07799999999997" svg_rhmargin="158.453" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="158.459,162.584" y="217.07799999999997" svg_rhmargin="164.601" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="85.212,87.618,91.742,95.867,98.27300000000001,101.595,106.497,110.621,114.746,118.482,123.477,130.949,132.966,137.99,143.354,147.479,151.215,155.34,160.382,166.606,170.73,172.74699999999999,177.785,183.15,187.274,191.01,195.135,198.87099999999998,203.918,207.654,213.796,215.813,220.812,224.077,226.483,231.527,235.263,237.28,239.297,244.339,248.852,252.976,257.1,259.977,263.242,266.119,268.996,271.013,275.137,279.262,282.139,287.195,291.32,293.726,298.76,304.125,307.39,311.126,313.532,318.897,323.93,325.948" y="226.03599999999994" svg_rhmargin="330.072" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[32] Tong M, Yuan HP, Zhang SQ, et al. Expressions of RegIV in</text>
  <text x="101.596,104.473,107.738,110.144,112.161,116.285,120.41,124.534,126.552,130.288,133.164,135.57,139.695,145.836,149.572,151.141,154.877,159.002,163.127,164.69,166.707,169.113,171.99,173.534,176.799,180.923,183.8,186.677,189.942,191.959,195.695,198.101,200.118,204.243,208.368,209.984,215.738,217.755,220.161,224.286,225.801,229.537,233.661,237.397,239.415,243.539,247.342,250.607,254.732,257.997,260.874,262.891,265.768,267.78499999999997,269.337,273.461,276.338,280.463,284.198,287.075,288.611,296.083,300.207,304.332,305.902,310.415,312.433,316.557,322.699,325.964" y="234.99300000000005" svg_rhmargin="330.088" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">retinoblastoma and its correlation with angiogenesis. Progr Mod Biomed</text>
  <text x="101.596,105.721,109.846,113.971,118.097,120.115,124.24,128.365,130.383,134.508" y="243.95000000000005" svg_rhmargin="138.632" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;17:88</text>
  <text x="138.673" y="243.95000000000005" svg_rhmargin="142.409" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="142.415,146.54,150.664" y="243.95000000000005" svg_rhmargin="152.681" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">92.</text>
  <text x="85.212,87.618,91.743,95.867,98.27300000000001,101.596,106.11,108.127,112.252,115.316,120.68,123.557,125.574,128.695,133.208,137.333,141.457,144.334,147.599,150.476,153.352,155.37,159.494,163.619,166.734,170.859,173.26500000000001,176.371,182.514,186.25,188.656,191.532,193.55,197.675,200.748,206.89,210.155,212.561,216.297,218.314,220.419,224.544,228.668,231.545,235.669,238.075,241.34,243.358,247.482,251.218,254.095,257.36,260.236,262.642,266.767,268.784,271.948,274.354,276.372,279.248,282.125,286.249,289.514,292.583,294.601,298.725,302.85,304.867,308.991,311.009,313.501,317.626,320.503,323.535,327.66" y="252.90700000000004" svg_rhmargin="330.066" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[33] Liu YJ. Expression of matrix metalloproteinases-9, tissue inhibitor of</text>
  <text x="101.597,107.738,111.004,113.41,117.145,119.163,121.18,125.305,129.429,132.306,136.43,138.836,142.101,144.119,148.243,151.979,154.856,158.121,160.527,164.652,167.922,171.657,175.782,179.907,183.115,186.851,190.587,193.463,196.728,200.853,202.87,206.606,209.483,212.706,215.971,220.096,224.22,228.409,230.815,234.939,238.204,240.222,242.239,245.975,247.992,251.198,254.934,257.81,261.935,267.688,270.094,274.219,277.445,279.851,283.586,286.852,289.258,293.382,296.259,299.497,301.514,305.639,308.851,311.728,314.993,317.399,319.416,323.54,327.665" y="261.92100000000005" svg_rhmargin="330.071" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">metalloproteinase-1 and vascular endothelial growth factor in retino-</text>
  <text x="101.597,105.721,107.738,111.474,114.351,116.757,120.881,127.023,130.759,133.285,135.691,137.709,140.585,143.462,147.586,150.851,153.728,155.745,158.284,161.161,163.67,169.424,171.442,175.566,179.69,181.708,185.444,189.568,193.304,195.813,203.286,206.551,210.676,213.217,218.582,222.706,224.724,228.45999999999998,230.961,235.086,239.21,243.334,247.459,249.476,253.601,257.725,259.815,263.94,268.065,272.189" y="270.879" svg_rhmargin="276.313" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">blastoma tissues. J Xinxiang Med Univ 2014;31:1015</text>
  <text x="276.323" y="270.879" svg_rhmargin="280.059" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="280.065,284.19" y="270.879" svg_rhmargin="286.207" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="85.212,87.618,91.743,95.867,98.27300000000001,101.596,109.068,112.334,116.458,120.194,122.968,127.482,130.359,132.376,135.157,139.67,143.794,147.919,150.795,154.061,156.937,159.814,161.831,165.956,170.081,172.854,176.979,179.38500000000002,182.152,189.623,197.095,201.22,203.693,207.818,210.553,214.289,218.413,222.538,225.292,230.657,235.17,240.995,245.12,247.855,249.872,253.997,256.755,259.632,262.897,265.303,267.32,271.445,275.569,279.771,281.788,285.524,288.401,290.807,294.931,301.073,304.80899999999997,307.605,310.011,312.028,314.905,317.781,321.906,325.171,328.047" y="279.836" svg_rhmargin="330.064" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[34] Meng LJ. Expression of MMP-9 and VEGF in retinoblastoma tissues.</text>
  <text x="101.597,105.333,109.458,113.195,117.32,121.445,123.935,131.408,134.674,138.799,141.284,144.161,146.67,150.795,154.92,159.045,163.17,165.188,169.314,173.439,175.529,179.654" y="288.793" svg_rhmargin="183.778" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Shand Med J 2011;51:96</text>
  <text x="183.744" y="288.793" svg_rhmargin="187.48" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="187.486,191.611" y="288.793" svg_rhmargin="193.628" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="85.212,87.618,91.743,95.867,98.27300000000001,101.596,109.068,112.804,116.929,120.665,125.633,131.386,135.899,137.916,142.866,149.008,151.026,155.151,160.157,165.522,168.399,170.416,175.407,182.879,186.61499999999998,191.564,194.441,201.912,203.929,208.911,215.136,217.542,221.666" y="297.75" svg_rhmargin="224.072" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[35] Wang XL, Niu YJ, Ma JM. HIF-</text>
  <text x="224.11" y="297.75" svg_rhmargin="228.698" style="fill:#171615;font-family:LFIAAE+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a</text>
  <text x="228.702,230.719,235.675,241.9,246.025,249.762,254.275,256.29200000000003,261.301,265.037,269.162,273.287,278.252,283.618,288.132,293.886,298.011,303.028,307.153,310.031,314.156,320.298,324.424,326.83" y="297.75" svg_rhmargin="330.095" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">, HPSE, and VEGF promote</text>
  <text x="101.597,107.738,111.474,113.492,115.509,119.245,123.37,127.105,131.23,133.636,136.007,140.131,143.008,147.132,150.868,153.745,157.01,159.886,162.763,164.86,168.985,173.11,175.405,179.529,181.935,184.305,187.182,190.447,192.853,194.87,198.995,203.119,207.243,209.261,212.997,215.873,218.279,222.404,228.546,232.281,234.298,236.741,242.106,246.231,248.248,252.373,254.712,257.589,259.928,266.07,270.194,274.319,276.724,280.849,284.585,286.602,292.744,296.868,298.885,301.31,305.434,309.558,313.683,317.807,319.825,323.949,328.074" y="306.707" svg_rhmargin="330.091" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">malignant progression of retinoblastoma. Chin J Ophthalmol 2010;46:</text>
  <text x="101.597,105.722,109.847" y="315.664" svg_rhmargin="113.971" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">140</text>
  <text x="113.956" y="315.664" svg_rhmargin="117.692" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="117.698,121.823" y="315.664" svg_rhmargin="123.84" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">4.</text>
  <text x="85.213,87.618,91.743,95.867,98.27300000000001,101.596,106.961,111.085,115.21,119.335,120.757,125.27,127.28699999999999,128.693,134.446,138.571,139.974,142.851,144.868,146.267,151.632,155.367,159.492,163.22799999999998,164.634,167.511,171.635,173.652,175.121,179.635,183.76,187.884,190.761,194.026,196.902,199.779,201.797,205.921,210.046,211.459,215.584,217.99,219.396,225.539,229.275,231.681,234.557,236.575,240.7,242.186,248.328,251.593,253.999,257.735,259.752,261.77,265.894,270.019,272.895,277.02,279.426,282.691,284.708,288.832,292.568,295.445,298.71,301.116,305.241,307.258,308.737,314.879,318.615,321.096,323.972,325.99" y="324.678" svg_rhmargin="330.114" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[36] Zhou L, Xu J, Kang JF. Expression of matrix metalloproteinase-1, matrix</text>
  <text x="101.597,107.738,111.004,113.41,117.145,119.163,121.18,125.305,129.429,132.306,136.43,138.836,142.101,144.119,148.243,151.979,154.856,158.121,160.527,164.652,167.922,171.658,175.782,179.907,183.115,186.851,190.587,193.463,196.728,200.853,202.87,206.606,209.483,212.706,215.971,220.096,224.22,228.409,230.815,234.939,238.204,240.222,242.239,245.975,247.992,251.198,254.934,257.81,261.935,267.688,270.094,274.219,277.445,279.851,283.587,286.852,289.258,293.382,296.259,299.497,301.514,305.639,308.851,311.728,314.993,317.399,319.416,323.54,327.665" y="333.636" svg_rhmargin="330.071" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">metalloproteinase-9 and vascular endothelial growth factor in retino-</text>
  <text x="101.597,105.721,107.738,111.474,114.351,116.757,120.881,127.023,130.759,133.285,137.021,141.146,145.271,147.798,151.063,153.08,155.098,159.222,161.24,164.505,168.241,170.258,172.798,175.674,177.692,181.428,185.552" y="342.593" svg_rhmargin="187.569" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">blastoma and clinical signi</text>
  <text x="187.599" y="342.593" svg_rhmargin="191.723" style="fill:#171615;font-family:LFHPIN+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="191.738,195.003,198.739,202.863,206.129,209.394,211.411,213.903,218.416,222.152,225.41699999999997,227.962,231.698,234.963,236.98,239.47,243.595,247.719,251.843,255.968,257.985,262.11,266.234,268.251,272.376" y="342.593" svg_rhmargin="276.5" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance. Eye Sci 2010;25:11</text>
  <text x="276.55" y="342.593" svg_rhmargin="280.286" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="280.292,284.417" y="342.593" svg_rhmargin="286.434" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">3.</text>
  <text svg_rhmargin="277.671" x="85.213,87.619,91.744,95.868,98.274,101.597,105.722,109.458,113.582,117.318,119.114,123.628,125.645,127.392,131.905,133.923,137.659,141.784,143.605,148.97,153.095,155.112,156.928,164.4,168.136,172.26,175.99599999999998,177.79,180.666,184.791,186.808,188.56,193.073,197.198,201.322,204.263,207.528,210.405,213.281,215.299,219.423,223.548,225.351,229.477,231.883,233.629,237.754,241.878,245.143,247.235,250.5,254.236,257.113,258.856,261.262,264.998,268.263,270.669,274.794,277.671" y="351.55" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[37] Fang L, Liao RF, Wang JF. Expression of nuclear factor </text>
  <text x="279.499" y="351.55" svg_rhmargin="283.623" style="fill:#171615;font-family:LFIAAE+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">k</text>
  <text x="283.637,288.15,289.93,293.666,297.79,301.915,303.706,307.442,311.178,314.054,317.319,321.444,323.461,327.197" y="351.55" svg_rhmargin="330.074" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">B and vascular</text>
  <text x="101.597,104.863,108.987,113.111,117.236,119.642,123.766,127.031,129.049,131.066,134.802,136.819,138.388,142.124,145.0,149.125,154.878,157.284,161.409,162.991,165.397,169.133,172.398,174.804,178.928,181.805,183.342,185.359,189.484,191.052,193.929,197.194,199.6,201.617,205.742,209.866,213.99,216.008,219.744,222.62,225.026,229.151,235.293,239.029,240.654,244.389,248.514,252.639,254.145,256.163,258.569,261.446,262.989,266.254,268.272,270.289,274.413,276.431,279.696,283.432,285.449,287.081,289.958,291.975,295.711,299.835" y="360.507" svg_rhmargin="301.852" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">endothelial growth factor in retinoblastoma and its clinical signi</text>
  <text x="301.892" y="360.507" svg_rhmargin="306.016" style="fill:#171615;font-family:LFHPIN+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="305.974,309.239,312.975,317.1,320.43,323.695,325.712,327.233" y="360.507" svg_rhmargin="330.11" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance. J</text>
  <text x="101.597,106.111,109.377,113.502,117.239,121.364,125.489,128.018,135.49,138.756,142.881,145.366,150.732,154.857,156.875,158.892,161.411,165.537,169.662,173.787,177.912,179.93,184.055,188.181,190.199,194.324,198.449" y="369.464" svg_rhmargin="202.573" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Bengbu Med Coll 2010;35:581</text>
  <text x="202.624" y="369.464" svg_rhmargin="206.36" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="206.366,210.491" y="369.464" svg_rhmargin="212.508" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">4.</text>
  <text x="85.213,87.619,91.744,95.868,98.274,101.597,107.739,109.757,113.882,117.867,123.232,126.109,128.126,132.153,136.667,138.684,142.809,146.78,150.905,155.418,157.435,161.463,166.828,170.564,174.688,178.42399999999998,182.438,187.803,189.82,193.832,197.098,199.50400000000002,203.469,207.205,209.223,211.24,215.261,220.625,223.891,225.908,229.644,232.05,234.067,238.192,242.316,245.193,249.317,251.335,255.46,259.534,263.659,266.924,269.33,275.083,278.348,281.613,285.738,289.749,293.485,297.221,300.098,303.363,307.487,309.505,313.629,317.365,320.63,324.755,326.772" y="378.478" svg_rhmargin="330.037" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[38] Niu YJ, Liu FL, Yang Y, et al. Relationship between vasculogenic</text>
  <text x="101.597,107.739,109.757,115.898,117.916,121.181,124.058,127.79400000000001,130.452,134.188,138.312,142.437,145.078,148.343,150.361,152.378,156.502,158.52,161.785,165.521,167.53799999999998,170.191,174.315,178.051,180.457,184.646,188.771,190.788,194.913,198.649,200.666,203.931,207.667,209.684,212.31,215.575,219.7,223.436,226.312,230.048,233.398,235.804,239.069,241.945,244.822,247.457,249.474,253.599,256.244,259.12,262.385,264.791,266.809,270.933,275.057,279.182,281.199,284.935,287.812,290.218,294.342,300.484,304.22,306.237,308.963,314.328,318.452,320.47,324.595,327.217" y="387.436" svg_rhmargin="330.094" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">mimicry and clinical pathological characters in retinoblastoma. Chin J</text>
  <text x="101.597,107.74,111.865,115.99,118.397,122.522,126.259,128.277,134.42,138.545,140.56199999999998,143.1,147.225,151.35,155.475,159.6,161.618,165.744,169.869,171.959,176.084,180.209" y="396.393" svg_rhmargin="184.333" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Ophthalmol 2009;45:318</text>
  <text x="184.312" y="396.393" svg_rhmargin="188.048" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="188.054,192.179,196.304" y="396.393" svg_rhmargin="198.321" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="85.213,87.619,91.744,95.868,98.274,101.597,106.962,111.087,112.709,115.585,117.60199999999999,119.285,124.187,127.923,132.048,133.684,138.197,145.669,147.686,149.33,156.802,160.538,164.662,168.398,170.022,177.494,182.859,184.876,186.575,189.84,192.246,193.888,197.624,199.642,201.659,203.299,207.812,211.936,216.061,218.938,222.203,225.079,227.956,229.973,234.098,238.223,239.92,244.044,246.45000000000002,248.084,254.225,257.961,260.367,263.244,265.261,269.386,271.042,277.184,280.449,282.855,286.591,288.608,290.713,294.838,298.962,301.839,305.963,308.369,311.634,313.652,317.776,321.512,324.389,327.654" y="405.35" svg_rhmargin="330.06" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[39] Yu J, Tao LM, Wang WY, et al. Expression of matrix metalloproteinase-</text>
  <text x="101.597,105.722,109.648,113.383,117.508,121.633,125.521,129.257,132.992,135.869,139.134,143.259,145.276,149.012,151.889,155.849,159.114,163.238,167.363,171.551,173.957,178.082,181.347,183.364,185.382,189.118,191.135,195.077,198.813,201.69,205.814,211.567,213.973,218.098,222.061,224.467,228.203,231.468,233.874,237.998,240.875,244.793,246.81,250.935,254.884,257.761,261.026,263.432,265.45,269.574,273.698,277.823,279.84,283.576,286.453,288.954,293.078,299.22,302.956,306.867,310.603,314.727,318.852,322.797,324.814,327.22" y="414.307" svg_rhmargin="330.097" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9 and vascular endothelial growth factor in retinoblastoma and its</text>
  <text x="101.597,104.863,106.88,108.897,113.022,115.039,118.304,122.04,124.057,126.597,129.473,131.491,135.227,139.351" y="423.264" svg_rhmargin="141.368" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">clinical signi</text>
  <text x="141.396" y="423.264" svg_rhmargin="145.52" style="fill:#171615;font-family:LFHPIN+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="145.535,148.8,152.536,156.66,159.925,163.19,165.207,167.7,170.577,173.085,177.599,180.864,184.989,188.725,192.849,196.974,199.503,206.975,210.24,214.365,216.851,222.215,226.34,228.357,230.374,232.893,237.018,241.142,245.267,249.391,251.409,255.533,259.657,261.747,265.872,269.996" y="423.264" svg_rhmargin="274.12" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance. J Bengbu Med Coll 2009;34:298</text>
  <text x="274.113" y="423.264" svg_rhmargin="277.849" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="277.855,281.979,286.104,290.228" y="423.264" svg_rhmargin="292.245" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">300.</text>
  <text x="85.213,87.62,91.745,95.87,98.27600000000001,101.599,104.476,106.494,110.231,114.356,118.092,121.159,126.525,128.542,131.591,137.345,141.47,144.517,147.394,152.759,154.77599999999998,157.84,163.205,167.331,171.067,175.192,178.928,181.992,187.358,194.831,196.84799999999998,199.908,205.273,208.354,211.232,213.639,217.764,221.889,225.625,228.652,232.778,235.184,238.29,242.415,247.781,253.923,259.289,261.306,264.37,269.735,274.249,280.003,284.128,287.218,290.484,294.609,298.734,301.611,304.877,307.755,310.632,312.65,316.775,320.9,323.959,325.977" y="432.221" svg_rhmargin="330.101" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[40] Jiang Y, Du JR, Zhang YM. A study of PCNA, VEGF expression in</text>
  <text x="101.597,104.474,107.739,110.145,112.163,116.287,120.411,124.536,126.553,130.289,133.166,135.572,139.696,145.838,149.574,151.591,154.147,159.513,163.249,167.373,170.638,173.904,176.781,179.318,183.442,186.319,189.584,193.32,195.814,201.179,204.444,207.321,209.873,213.997,218.122,222.246,226.371,228.388,232.512,236.637,238.654,242.779,246.903" y="441.235" svg_rhmargin="251.027" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">retinoblastoma. Cancer Prev Res 2004;31:255</text>
  <text x="251.095" y="441.235" svg_rhmargin="254.831" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="254.837,258.962" y="441.235" svg_rhmargin="260.979" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">6.</text>
  <text x="85.213,87.619,91.744,95.868,98.274,101.597,105.722,109.847,111.745,116.647,120.383,124.507,126.524,128.469,132.205,136.329,140.454,144.19,146.099,151.853,159.325,161.34199999999998,163.276,167.789,169.80599999999998,171.723,176.236,178.253,180.17,183.435,185.841,187.71,191.446,193.463,195.48,197.404,199.81,205.952,212.093,216.218,220.419,224.544,228.668,230.685,233.562,235.968,240.092,243.358,247.482,250.747,256.889,258.906,262.172,265.908,267.925,269.908,272.785,275.19,279.315,283.439,285.457,288.722,291.599,293.547,297.672,301.797,303.695,307.431,311.166,314.043,317.308,321.433,323.45,327.186" y="450.193" svg_rhmargin="330.063" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[41] Fu Tao, Song XW, Li L, et al. Immunohistochemical studies on vascular</text>
  <text x="101.597,104.863,108.987,113.111,117.236,119.642,123.766,127.031,129.049,131.066,134.802,136.819,139.522,143.258,146.135,150.259,156.012,158.418,162.543,165.259,167.665,170.361,174.097,177.362,179.768,183.893,186.77,189.465,191.482,195.607,198.309,201.185,204.45,206.856,208.874,212.998,217.123,221.324,223.341,227.077,229.954,232.36,236.484,242.626,246.362,248.379,251.085,256.45,260.574,262.592,266.717,269.395,272.272,274.951,281.094,284.359,288.557,290.574,293.206,297.331,301.455,305.58,309.704,313.898,316.77500000000003,319.454,325.208,327.225" y="459.15" svg_rhmargin="330.102" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">endothelial growth f actor in retinoblastoma. Chin J Ocul Fundus Dis</text>
  <text x="101.597,105.723,109.848,113.973,118.098,120.116,124.241,128.367,130.385,134.51,138.635" y="468.107" svg_rhmargin="142.759" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">1999;15:238</text>
  <text x="142.813" y="468.107" svg_rhmargin="146.549" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="146.555,150.68,154.805" y="468.107" svg_rhmargin="156.822" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">40.</text>
  <text x="85.213,87.619,91.744,95.868,98.274,101.597,106.961,111.086,115.21,118.087,120.964,124.229,126.635,135.383,141.525,145.261,147.278,155.962,159.698,163.434,165.451,169.576,178.298,183.663,191.135,193.152,201.882,204.288,210.429,216.571,220.696,224.82,228.945,233.069,235.086,237.963,240.369,244.493,247.759,251.883,255.148,261.404,263.422,266.687,270.423,272.44,281.133,284.398,288.522,292.647,295.523,298.789,301.665,304.542,306.559,310.684,314.809,323.536,327.66" y="477.064" svg_rhmargin="330.066" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[42] Youssef NS, Said AM. Immunohistochemical expression of</text>
  <text x="101.597,106.962,112.715,116.84,120.964,125.089,129.829,133.565,137.689,141.814,146.552,150.288,154.024,156.901,160.166,164.29,166.308,170.044,172.92100000000002,177.731,180.997,185.121,189.245,193.37,195.776,199.9,203.165,205.183,207.2,210.936,212.953,217.753,221.489,224.366,228.49,234.244,236.649,240.774,245.531,247.937,251.673,254.938,257.344,261.469,264.346,269.114,271.131,275.256,279.999,282.875,286.14,288.546,290.564,294.688,298.813,303.014,305.031,308.767,311.644,314.05,318.174,324.316,328.052" y="486.021" svg_rhmargin="330.069" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">CD117 and vascular endothelial growth factor in retinoblastoma:</text>
  <text x="101.597,105.722,109.846,112.723,115.6,117.617,121.741,123.759,127.024,131.813,134.219,137.954,140.831,144.567,147.832,150.238,153.115,157.946,162.07,164.476,169.284,173.409,176.674,182.42700000000002,187.256,189.662,193.786,197.051,199.928,203.664,207.788,209.806,213.071,215.947,217.964,222.799,225.205,229.329,231.735,236.518,239.395,244.171,249.536,251.553,253.571,257.696,262.539,267.051,271.176,275.301,280.055,284.181,287.916,290.322,294.447,298.571,300.588,305.396,309.52,313.645,317.769,321.894,323.911,328.035" y="495.035" svg_rhmargin="330.052" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">possible targets of new therapies. Int J Clin Exp Pathol 2014;7:</text>
  <text x="101.597,105.723,109.848,113.973" y="503.993" svg_rhmargin="118.097" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5725</text>
  <text x="118.095" y="503.993" svg_rhmargin="121.831" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="121.837,125.962,130.087" y="503.993" svg_rhmargin="132.104" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">37.</text>
  <text x="85.214,87.62,91.744,95.869,98.275,101.597,106.962,111.087,115.211,117.228,120.964,125.089,127.731,131.855,133.87199999999999,136.461,140.585,143.85,146.495,152.248,155.125,158.861,162.596,165.002,167.639,171.764,173.781,176.426,180.162,183.898,188.023,190.599,194.723,197.988,200.865,203.524,208.889,212.625,214.642,218.767,221.381,225.505,227.522,230.168,233.433,235.839,238.444,242.18,244.197,246.214,248.875,254.24,257.505,259.911,261.928,266.052,270.177,274.301,276.319,280.055,282.931,285.337,289.462,295.603,299.339,301.356,304.032,307.768,311.503,313.521,317.645,320.90999999999997,323.532,327.657" y="512.95" svg_rhmargin="330.063" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[43] Rodjan F, de Graaf P, van der Valk P, et al. Retinoblastoma: value of</text>
  <text x="101.598,105.723,109.459,113.583,117.319,123.461,125.478,128.743,132.153,135.419,139.543,143.667,146.073,148.95,152.686,155.563,157.968,160.374,163.64,167.764,171.888,175.624,179.749,183.116,186.381,190.506,193.887,201.359,206.72400000000002,210.1,212.117,218.259,221.995,225.731,227.748,231.873,235.60899999999998,239.011,242.747,246.872,250.997,254.431,257.696,261.82,264.697,267.574,270.839,272.856,276.592,278.998,281.016,285.14,289.265,292.695,298.449,300.466,302.872,306.997,310.383,312.789,316.913,323.055,327.179" y="521.9069999999999" svg_rhmargin="330.056" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">dynamic contrast-enhanced MR imaging and correlation with tumor</text>
  <text x="101.598,105.334,109.459,113.194,115.212,119.336,123.072,126.337,130.462,133.727,136.604,138.621,141.498,143.515,146.041,151.406,154.283,160.497,165.86200000000002,168.321,173.685,179.827,182.38,185.257,187.708,193.851,197.116,201.315,204.191,208.316,211.192,214.928,219.053,221.07,225.194,227.21099999999998,229.716,233.84,237.965,242.089,246.213,248.231,252.355,256.48,258.569,262.694,266.818,270.943" y="530.864" svg_rhmargin="275.067" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">angiogenesis. AJNR Am J Neuroradiol 2012;33:2129</text>
  <text x="275.078" y="530.864" svg_rhmargin="278.814" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="289.087" x="278.82,282.945,287.07,289.087" y="37.75199999999995" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">35. </text>
  <text x="345.206,347.612,351.737,355.861,358.267,361.59,366.103,368.12,372.872,379.096,384.46,386.477,391.239,395.752,399.876,404.001,406.877,410.142,413.019,415.896,417.913,422.037,426.162,430.921,435.045,437.451,442.146,448.288,452.024,454.505,457.381,459.399,463.524,468.224,474.365,477.631,480.036,483.772,485.79,487.895,492.019,496.143,499.02,503.144,505.55,508.816,510.833,514.957,518.693,521.57,524.835,527.241,531.366,533.383,538.177,542.302,547.021,550.757,554.882,559.007,563.745,567.48,571.216,574.093,577.358,581.483,583.5,587.236" y="37.75199999999995" svg_rhmargin="590.113" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[44] Li HY. Expression of matrix metalloproteinase-1, 9 and vascular</text>
  <text x="361.591,364.856,368.98,373.105,377.229,379.635,383.759,387.1,389.117,391.135,394.871,396.888,399.118,402.854,405.731,409.855,415.609,418.015,422.14,424.402,426.807,430.543,433.809,436.214,440.339,443.216,445.547,447.564,451.689,453.937,456.813,460.079,462.484,464.502,468.626,472.751,476.875,478.893,482.628,485.505,487.911,492.035,498.177,501.913,504.219,506.625,508.642,511.519,514.396,518.52,521.785,524.662,526.6790000000001,528.992,534.356,538.481,540.498,544.623,546.849,549.726,552.008,559.48,562.745,566.87,569.071,573.196,577.321,581.057,583.933" y="46.708999999999946" svg_rhmargin="590.075" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">endothelial growth factor in retinoblastoma tissues. Chin J Med Pharm</text>
  <text x="361.591,365.715,369.839,373.964,378.088,380.106,384.23,388.355,390.444,394.569,398.693,402.818" y="55.66700000000003" svg_rhmargin="406.942" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2012;19:2472</text>
  <text x="406.944" y="55.66700000000003" svg_rhmargin="410.68" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="410.686,414.812" y="55.66700000000003" svg_rhmargin="416.829" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">3.</text>
  <text x="345.206,347.612,351.737,355.861,358.267,361.59,366.955,370.691,374.815,378.939,382.675,386.873,389.75,391.767,394.644,398.768,402.892,406.628,410.753,412.213,417.577,419.594,421.056,426.421,430.157,433.034,437.158,440.894,444.63,448.755,450.251,453.987,456.004,457.451,461.187,463.204,467.328,471.064,475.189,476.668,481.181,483.198,484.662,487.927,490.333,491.805,495.54,497.558,499.575,501.045,506.41,510.923,516.676,520.801,522.247,525.512,529.637,533.761,536.703,539.968,542.845,545.721,547.739,551.863,555.988,557.45,559.468,563.593,565.047,567.924,571.189,574.066,576.083,580.207,584.332,588.068" y="64.62400000000002" svg_rhmargin="590.085" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[45] Radhakrishnan V, Kashyap S, Singh L, et al. VEGF expression in residual</text>
  <text x="361.591,363.997,368.121,374.263,378.387,381.264,382.905,386.171,389.436,391.453,393.471,396.348,397.985,400.002,404.127,405.752,409.876,412.753,416.877,418.895,421.301,425.037,427.054,428.711,431.587,434.852,437.258,439.276,443.4,447.524,451.726,453.743,457.479,460.356,462.762,466.886,473.028,476.764,478.426,480.832,483.238,488.603,492.339,496.075,497.701,500.577,502.983,506.719,510.455,513.72,515.331,517.737,520.143,522.549,524.9549999999999,526.612,529.018,531.895,535.16,538.896,541.302,544.567,548.692,550.365,556.118,558.136,560.542,564.667,566.295,572.437,577.802,583.166,588.068" y="73.58100000000002" svg_rhmargin="590.085" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">tumor cells in orbital retinoblastoma (IRSS stage III) treated with NACT:</text>
  <text x="361.587,365.323,367.823,371.948,374.824,378.949,381.825,385.95,389.215,392.48,394.886,396.903,400.639,403.904,406.485,409.361,411.767,415.892,420.016,423.752,425.769,428.253,432.377,435.642,439.767,441.858,445.594,448.0,450.877,453.366,457.879,459.897,464.021,468.146,472.271,474.795,480.16,483.896,488.02,491.286,494.551,497.428,499.965,504.089,508.214,512.338,516.463,518.48,522.604,526.729,528.746,532.871,536.995" y="82.55100000000004" svg_rhmargin="541.119" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a prospective study. Pediatr Blood Cancer 2012;59:567</text>
  <text x="541.189" y="82.55100000000004" svg_rhmargin="544.925" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="544.931,549.056" y="82.55100000000004" svg_rhmargin="551.073" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,366.951,371.076,374.812,378.937,383.639,387.375,393.517,395.534,400.192,403.928,408.052,412.177,415.913,420.543,426.767,428.784,433.469,437.982,442.106,446.231,449.107,452.373,455.249,458.126,460.143,464.268,468.393,473.094,476.83,480.954,485.079,489.704,492.969,494.986,497.004,501.128,503.146,506.411,510.147,512.164,516.858,518.875,525.017,529.216,531.234,533.251,536.516,540.252,542.658,544.676,548.8,552.925,557.617,561.742,564.1479999999999,568.786,574.927,578.663,581.069,583.946,585.963" y="91.56500000000005" svg_rhmargin="590.087" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[46] Yuan SQ, Song H. Expression and clinical implication of matrix</text>
  <text x="361.587,367.729,370.994,373.4,377.136,379.154,381.258,385.383,389.507,392.384,396.508,398.914,402.179,404.197,408.321,412.057,414.934,418.199,420.605,424.73,427.969,431.705,435.829,439.954,443.162,446.898,450.634,453.511,456.776,460.9,462.918,466.653,469.53000000000003,472.753,476.019,480.143,484.267,488.392,490.798,494.922,498.187,500.205,502.222,505.958,507.975,511.244,514.98,517.857,521.981,527.735,530.141,534.266,537.491,539.897,543.633,546.898,549.304,553.429,556.3059999999999,559.543,561.56,565.685,568.84,571.717,574.982,577.388,579.405,583.53,587.654" y="100.52200000000005" svg_rhmargin="590.06" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">metalloproteinase-1 and vascular endothelial growth factor in retino-</text>
  <text x="361.587,365.712,367.729,371.465,374.342,376.748,380.872,387.098,390.833,392.85,395.318,399.832,403.568,406.83299999999997,409.378,413.114,416.379,418.396,420.886,425.01,429.135,433.259,437.383,439.401,443.525,447.65,449.667,453.791" y="109.48000000000002" svg_rhmargin="457.915" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">blastoma. Eye Sci 2010;25:48</text>
  <text x="457.965" y="109.48000000000002" svg_rhmargin="461.701" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="461.706,465.832,469.957" y="109.48000000000002" svg_rhmargin="471.974" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">51.</text>
  <text x="345.203,347.61,351.735,355.86,358.266,361.589,367.343,370.608,374.572,379.937,381.954,385.967,390.481,392.498,396.455,401.821,404.698,406.715,410.686,415.2,417.218,421.343,425.314,429.827,431.844,435.802,440.315,444.441,448.566,451.507,454.773,457.65,460.527,462.545,466.671,470.796,474.753,478.878,481.284,485.298,492.77,500.243,504.368,506.775,510.9,514.835,519.738,522.144,529.689,533.814,536.221,540.346,544.317,548.053,552.178,556.303,560.247,565.613,570.127,575.881,580.006,584.003,586.021" y="118.43700000000001" svg_rhmargin="590.145" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[47] Ge Z, Li YJ, Liu B. Expression of MMP-9 TIMP-1 and VEGF in</text>
  <text x="361.587,364.464,367.729,370.135,372.152,376.277,380.401,384.603,386.62,390.356,393.233,395.639,399.763,405.905,409.641,411.658,414.194,417.93,422.054,425.79,429.915,434.039,438.163,442.288,446.024,448.547,456.019,459.284,463.409,465.894,468.771,471.28,475.404,479.529,483.653,487.778,489.795,493.919,498.044,500.061,504.186" y="127.394" svg_rhmargin="508.31" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">retinoblastoma. Shandong Med J 2007;47:53</text>
  <text x="508.364" y="127.394" svg_rhmargin="512.1" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="512.106,516.231" y="127.394" svg_rhmargin="518.248" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,365.711,368.588,370.605,373.011,376.276,380.4,384.136,387.096,391.221,396.734,401.247,408.719,410.736,416.291,422.045,425.78,429.046,431.923,437.493,444.965,450.33,452.347,457.958,463.711,467.836,471.572,477.119,482.484,487.849,489.866,495.43,499.554,502.431,506.555,510.291,513.168,516.433,519.31,522.1869999999999,527.799,529.816,533.941,539.477,542.354,548.496,552.232,554.249,556.2660000000001,561.87,568.012,572.136,574.153,577.419,580.684,584.808,586.826" y="136.351" svg_rhmargin="590.091" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[48] Pritchard EM, Dyer MA, Guy RK. Progress in small molecule</text>
  <text x="361.587,363.993,368.118,371.383,374.259,377.995,382.12,385.385,389.592,391.997,394.015,397.28,400.157,402.574,404.98,409.104,411.981,414.365,416.771,420.895,424.15999999999997,426.61,429.016,431.892,435.157,438.893,441.299,447.441,450.706,454.831,457.237,459.659,463.783,466.189,468.616,471.493,474.758,477.164,479.181,483.306,487.43,491.555,493.572,497.308,500.184,502.59,506.715,512.857,516.593,518.61,521.109,528.581,530.598,534.723,536.74,539.136,544.501,547.766,551.502,553.932,561.405,564.67,568.795,571.223,576.588,580.713,583.978" y="145.365" svg_rhmargin="590.12" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">therapeutics for the treatment of retinoblastoma. Mini Rev Med Chem</text>
  <text x="361.587,365.712,369.836,373.961,378.085,380.102,384.227,388.351,390.441,394.565,398.69" y="154.32299999999998" svg_rhmargin="402.814" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2016;16:430</text>
  <text x="402.802" y="154.32299999999998" svg_rhmargin="406.538" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="406.544,410.67,414.795" y="154.32299999999998" svg_rhmargin="416.812" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">54.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,365.322,369.447,373.183,377.308,383.072,388.436,392.561,394.578,400.305,404.041,408.166,410.183,413.448,415.466,419.59,422.467,428.253,433.618,438.131,440.14799999999997,445.883,449.619,453.744,455.761,459.026,461.044,465.168,468.045,473.774,476.651,482.015,484.032,489.818,495.183,499.307,502.573,508.714,512.839,515.245,519.369,522.634,525.511,529.247,533.371,537.107,542.879,545.284,549.409,552.286,558.015,564.157,567.893,569.91,571.927,575.663,579.788,583.524,587.648" y="163.27999999999997" svg_rhmargin="590.054" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[49] Shah CP, Shields CL, Shields JA. Chemotherapy for malignant</text>
  <text x="361.587,363.605,367.729,370.135,373.012,376.748,380.872,384.137,388.344,390.361,394.097,396.974,399.455,401.861,405.985,412.127,416.252,419.128,422.005,424.022,426.552,432.306,435.571,439.307,441.858,448.001,452.125,456.25,458.656,462.78,466.516,468.533,474.675,478.799,480.816,483.354,487.479,491.603,495.728,499.852,501.869,505.994,510.118,512.136,516.26,520.385" y="172.23699999999997" svg_rhmargin="524.509" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">intraocular tumors. Dev Ophthalmol 2016;55:337</text>
  <text x="524.579" y="172.23699999999997" svg_rhmargin="528.315" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="528.32,532.446,536.571" y="172.23699999999997" svg_rhmargin="538.588" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">43.</text>
  <text x="345.203,347.609,351.733,355.858,358.264,361.587,365.322,369.447,371.464,374.729,376.747,380.871,383.748,386.756,392.121,396.634,398.651,401.665,405.79,409.914,411.931,415.197,419.322,422.3,426.813,434.285,436.302,439.307,444.671,447.548,449.565,453.301,456.178,459.205,462.081,467.835,469.852,472.81,476.075,478.481,481.484,485.22,487.238,489.255,492.256,497.62,500.886,503.291,505.309,509.433,513.558,517.682,519.7,523.435,526.312,528.819,532.943,539.085,542.821,545.769,548.175,551.051,555.176,559.3,561.706,563.724,567.084,569.96,572.837,575.814,581.567,583.584,585.99" y="181.19399999999996" svg_rhmargin="590.114" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[50] Shields CL, Fulco EM, Arias JD, et al. Retinoblastoma frontiers with</text>
  <text x="361.587,363.605,367.729,370.135,373.012,376.748,380.483,383.749,387.873,392.086,396.21,399.087,401.104,404.558,406.575,410.699,413.105,415.982,419.718,422.124,425.86,428.82,431.226,434.491,437.368,439.385,443.121,445.138,447.155,450.645,454.77,458.035,460.911,462.929,467.053,470.318,474.443,476.46,480.196,483.073,485.09,488.626,492.362,496.487,500.612,504.103,506.12,510.245,512.651,515.527,519.263,522.999,525.016,527.422,530.299,533.564,537.3,539.317,542.821,546.086,550.211,553.476,559.618,563.742,566.233,570.358,573.623,576.5,580.236,584.36,588.096" y="190.15099999999995" svg_rhmargin="590.113" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">intravenous, intra-arterial, periocular, and intravitreal chemotherapy.</text>
  <text x="361.587,366.1,369.836,373.101,375.646,379.771,383.895,388.019,392.144,394.161,398.286,402.41,404.428,408.552,412.676" y="199.10900000000004" svg_rhmargin="416.8" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Eye 2013;27:253</text>
  <text x="416.863" y="199.10900000000004" svg_rhmargin="420.599" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="420.605,424.73,428.855" y="199.10900000000004" svg_rhmargin="430.872" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">64.</text>
  <text x="345.204,347.61,351.734,355.859,358.265,361.587,367.341,371.076,374.342,377.219,379.047,386.519,391.884,393.901,395.714,401.079,405.203,409.328,412.204,414.222,417.957,422.082,425.347,428.706,431.112,436.866,440.602,442.619,444.636,448.761,452.885,457.01,458.865,464.23,466.247,468.048,475.52,477.538,479.555,482.432,486.556,490.681,492.481,499.953,507.425,509.442,511.302,516.667,519.543,522.808,524.624,528.749,531.155,532.958,537.082,539.959,543.224,546.489,548.506,550.524,554.648,556.666,559.931,563.667,565.6840000000001,567.537,573.679,577.803,581.928,585.193,587.211" y="208.12300000000005" svg_rhmargin="590.088" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[51] Dyer MA, Rodriguez-Galindo C, Wilson MW. Use of preclinical models</text>
  <text x="361.588,363.994,368.119,370.659,372.676,378.818,382.942,385.819,389.943,393.679,396.94399999999996,399.457,401.862,404.739,408.004,411.74,414.146,420.288,423.553,427.677,430.083,432.619,436.744,439.15000000000003,441.69,444.567,447.832,450.238,452.255,456.38,460.504,464.628,466.646,470.382,473.258,475.664,479.789,485.931,489.666,491.683,494.24,498.364,502.877,507.002,510.738,513.288,520.76,524.025,528.15,530.634,534.76,538.884,543.008,547.133,549.15,553.275,555.292,558.557,562.682,566.806,570.931" y="217.08000000000004" svg_rhmargin="572.948" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">to improve treatment of retinoblastoma. PLoS Med 2005;2:e332.</text>
  <text x="345.204,347.61,351.734,355.859,358.265,361.587,366.952,371.076,375.201,378.077,380.095,383.831,387.955,391.22,394.58,396.986,402.739,406.475,408.492,410.51,414.634,418.758,422.883,427.175,432.54,434.557,438.854,446.326,448.343,450.36,453.31,457.434,461.559,465.838,473.31,480.782,482.799,487.096,493.32,497.056,499.074,503.199,507.505,512.018,517.771,519.788,524.058,527.323,529.7289999999999,534.036,537.772,539.789,541.806,546.111,551.013,553.89,557.155,560.891,563.297,569.439,572.704,576.828,579.2339999999999,583.583,587.707" y="226.03700000000003" svg_rhmargin="590.113" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[52] Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of</text>
  <text x="361.588,363.605,367.73,370.136,373.012,376.748,380.873,384.138,388.344,390.362,394.098,396.975,398.378,401.255,404.52,406.926,408.944,413.068,417.192,421.317,423.334,427.07,429.947,432.353,436.477,442.619,446.355,447.81,453.564,455.582,457.988,462.113,463.571,467.306,469.324,473.448,476.713,479.59,481.607,484.484,486.89,488.907,493.032,496.29699999999997,497.753,501.489,505.614,509.739,511.132,514.397,518.133,521.01,525.134,529.329,533.454,535.472,539.208,541.614,543.631,547.755,549.772,551.212,554.0889999999999,555.464,560.83,562.847,564.864,568.989,570.431,576.573,580.697,583.962,588.087" y="234.99400000000003" svg_rhmargin="590.104" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol</text>
  <text x="361.588,365.712,369.837,373.961,378.086,380.103,384.228,388.352,390.442,394.566,398.691,402.815" y="243.95100000000002" svg_rhmargin="406.939" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2003;21:2019</text>
  <text x="406.942" y="243.95100000000002" svg_rhmargin="410.678" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="410.684,414.809,418.934" y="243.95100000000002" svg_rhmargin="420.951" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">25.</text>
  <text x="345.204,347.61,351.734,355.859,358.265,361.587,369.059,372.795,374.812,376.83,378.847,382.972,386.707,389.194,393.318,397.054,399.455,404.82,410.185,412.202,414.591,420.344,422.361,428.503,432.239,435.116,438.852,441.729,444.182,450.406,452.423,454.84,460.205,464.329,468.065,472.19,474.624,480.848,484.584,489.097,491.114,493.502,496.767,499.173,501.609,505.345,507.362,509.379,511.813,515.937,519.203,522.079,524.097,528.221,531.486,535.611,537.628,541.364,544.241,546.677,549.082,553.207,557.331,561.456,563.862,567.127,570.392,574.128,578.253,580.69,583.096,587.22" y="252.909" svg_rhmargin="590.097" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[53] Mallipatna AC, Dimaras H, Chan HSL, et al. Periocular topotecan for</text>
  <text x="361.588,363.605,367.73,370.136,373.012,376.748,380.873,384.138,388.344,390.362,394.098,396.975,399.456,402.332,405.598,408.004,410.021,414.145,418.27,422.471,424.489,428.224,431.101,433.507,437.631,443.773,447.509,449.526,452.062,457.428,460.305,463.57,467.695,470.204,476.346,480.47,484.595,487.001,491.125,494.861,496.878,503.02,507.144,509.161,511.699,515.824,519.948,524.073,528.197,530.214,534.339,538.463,542.588,544.692,548.816,552.941" y="261.923" svg_rhmargin="557.065" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">intraocular retinoblastoma. Arch Ophthalmol 2011;129:738</text>
  <text x="557.064" y="261.923" svg_rhmargin="560.8" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="560.806,564.93,569.055" y="261.923" svg_rhmargin="571.072" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">45.</text>
  <text x="345.204,347.61,351.734,355.859,358.265,361.587,367.729,370.994,377.136,380.401,382.807,386.932,392.199,397.564,405.036,407.053,412.324,416.448,419.713,423.838,427.103,429.979,431.997,435.262,439.387,444.636,448.372,450.389,455.578,460.943,464.679,467.555,470.82,474.625,478.749,482.874,485.75,489.875,495.09,500.455,507.927,509.944,515.215,518.48,520.886,526.1,529.836,531.853,533.87,539.082,542.818,546.942,551.067,554.332,558.456,562.581,564.598,568.723,572.925,576.19,578.596,580.613,584.349,588.085" y="270.88" svg_rhmargin="590.102" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[54] Nemeth KM, Federico S, Carcaboso AM, et al. Subconjunctival</text>
  <text x="361.588,364.853,368.589,371.466,375.59,379.715,383.839,385.856,389.592,392.086,394.103,398.228,401.1,404.835,408.96,413.085,415.952,418.829,422.565,425.441,427.847,431.112,437.254,439.271,442.536,445.43,447.836,451.96,456.084,460.209,462.615,465.88,469.145,472.881,477.006,479.896,482.302,485.179,488.444,492.18,494.586,500.814,504.079,508.204,510.61,513.456,515.473,519.598,522.47,526.594,529.471,532.736,536.001,538.019,540.036,544.161,546.178,549.443,553.179,555.196,558.127,564.269,568.393,572.518,575.783,577.8,580.6769999999999,583.58,587.705" y="279.837" svg_rhmargin="590.111" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carboplatin and systemic topotecan treatment in preclinical models of</text>
  <text x="361.588,364.465,367.73,370.136,372.153,376.278,380.402,384.603,386.621,390.357,393.233,395.639,399.764,405.905,409.641,411.658,414.195,419.56,423.296,427.42,430.686,433.951,436.82800000000003,439.365,443.489,447.614,451.738,455.863,457.88,462.004,466.129,470.253,472.271,476.395,480.519" y="288.794" svg_rhmargin="484.643" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">retinoblastoma. Cancer 2011;117:421</text>
  <text x="484.668" y="288.794" svg_rhmargin="488.404" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="488.41,492.535,496.66" y="288.794" svg_rhmargin="498.677" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,366.101,369.366,372.631,374.457,378.193,383.557,385.574,387.438,392.803,394.82,400.962,402.801,408.555,410.961,416.326,418.343,420.205,425.57,429.695,433.82,435.682,438.559,444.783,446.8,448.607,451.872,454.278,456.146,459.882,461.9,463.917,465.727,468.133,472.257,476.382,478.399,482.523,484.541,486.947,491.071,493.948,497.68399999999997,499.57,502.835,505.241,507.647,510.912,514.177,516.583,518.447,522.572,524.978,526.837,530.962,534.227,537.963,541.699,544.964,546.981,550.246,554.371,560.513,564.249,568.374,570.26,574.385,578.51,580.294,582.7,586.825" y="297.751" svg_rhmargin="590.09" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[55] Lee SY, Kim D-K, Cho JH, et al. Inhibitory effect of bevacizumab on the</text>
  <text x="361.589,365.325,369.449,373.185,375.202,379.327,383.13,386.395,390.52,393.785,396.661,398.679,401.556,404.955,408.691,412.815,416.94,420.318,424.054,426.93,431.055,436.808,439.214,443.339,446.735,450.859,453.265,456.656,459.533,462.798,465.204,467.221,471.346,475.47,479.671,481.689,485.425,488.301,490.707,494.832,500.974,504.709,506.726,510.17,515.535,518.411,521.676,525.801,529.161,535.303,539.427,543.617,546.023,550.147,553.883,555.9,562.042,566.167,568.1840000000001,571.564,575.689,579.813,583.938,588.062" y="306.709" svg_rhmargin="590.079" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">angiogenesis and growth of retinoblastoma. Arch Ophthalmol 2008;</text>
  <text x="361.589,365.714,369.839,373.964,375.982,380.108,384.233" y="315.666" svg_rhmargin="388.357" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">126:953</text>
  <text x="388.404" y="315.666" svg_rhmargin="392.14" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="392.146,396.271" y="315.666" svg_rhmargin="398.288" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,367.341,369.359,373.095,375.5,378.377,382.502,388.643,392.379,396.504,400.628,402.743,406.479,410.604,412.621,417.029,422.394,424.411,428.765,434.129,438.254,442.378,446.503,450.627,454.751,457.628,461.364,465.555,467.572,470.449,474.852,482.324,484.73,486.747,491.122,494.858,496.875,500.611,503.488,505.505,509.63,511.647,514.524,518.956,523.469,525.4860000000001,529.897,533.162,535.568,539.932,543.667,545.685,547.702,552.12,557.484,560.749,562.767,566.503,568.909,570.926,575.051,579.176,583.582,587.706" y="324.68" svg_rhmargin="590.112" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[56] Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of</text>
  <text x="361.589,365.713,369.449,373.573,377.698,381.883,383.9,387.63599999999997,391.123,393.141,397.265,401.389,405.514,408.779,410.796,414.921,416.938,420.203,423.776,426.182,429.918,433.183,435.589,439.713,442.59000000000003,446.111" y="333.637" svg_rhmargin="450.235" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">hypoxia inducible factor 1</text>
  <text svg_rhmargin="454.844" x="450.256,454.844" y="333.637" style="fill:#171615;font-family:LFIAAE+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a </text>
  <text x="458.363,462.099,466.225,470.35,473.897" y="333.637" svg_rhmargin="478.021" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and 2</text>
  <text svg_rhmargin="482.623" x="478.035,482.62300000000005" y="333.637" style="fill:#171615;font-family:LFIAAE+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a </text>
  <text x="486.142,488.16,492.285,495.779,499.904,504.028,507.293,510.17,513.906,518.03,520.048,523.313,526.845,530.969,535.094,539.218,541.697,544.574,550.716,554.452,556.469,558.4860000000001,561.992,565.258,568.523,570.54,572.557,576.108,578.125,582.25,586.374" y="333.637" svg_rhmargin="590.11" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in operable non-small cell lung</text>
  <text x="361.589,364.854,368.59,372.714,375.979,379.245,382.122,385.511,387.917,392.042,395.432,399.168,403.293,407.028,409.046,413.17,416.906,420.171,424.296,426.313,429.578,431.596,437.835,441.959,443.977,447.242,450.507,454.631,456.649,460.385,463.262,466.632,470.757,473.634" y="342.594" svg_rhmargin="477.758" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer to angiogenic/molecular pro</text>
  <text x="477.809" y="342.594" svg_rhmargin="481.933" style="fill:#171615;font-family:LFHPIN+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="481.948,483.965,487.22999999999996,490.565,494.689,497.095,500.486,502.892,507.016,513.158,517.282,521.407,524.284,527.161,530.587,534.323,538.448,542.573,545.95,548.827,552.951,555.828,559.564,561.581,565.317,569.053,571.07,573.0870000000001,576.505,581.018,583.895,587.277" y="342.594" svg_rhmargin="590.154" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">le of tumours and survival. Br J</text>
  <text x="361.59,366.954,370.69,374.815,378.08,381.345,384.22200000000004,386.759,390.883,395.008,399.132,403.257,405.274,409.398,413.523,415.613,419.737,423.862" y="351.551" svg_rhmargin="427.986" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cancer 2001;85:881</text>
  <text x="427.976" y="351.551" svg_rhmargin="431.712" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="431.718,435.844,439.969" y="351.551" svg_rhmargin="441.986" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">90.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,365.325,371.466,373.484,375.89,380.015,381.43,385.943,391.696,393.713,395.149,398.885,405.027,407.044,409.45,413.575,414.934,420.687,425.2,427.217,428.653,434.017,437.753,440.63,443.036,446.301,449.178,450.591,456.345,458.362,459.718,462.983,465.389,466.804,470.54,472.558,474.575,475.988,483.46,487.584,489.602,492.867,496.132,500.256,502.274,506.01,508.887,510.284,516.426,520.162,523.039,527.163,530.428,533.305,534.717,537.982,542.107,546.231,549.108,552.373,555.25,558.126,560.144,564.268,568.393,569.807,571.825,575.95,577.347,581.471,584.348,588.084" y="360.508" svg_rhmargin="590.101" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[57] Smith BD, Smith GL, Carter D, et al. Molecular marker expression in oral</text>
  <text x="361.59,365.325,369.45,373.575,376.386,380.51,383.387,387.511,391.636,395.76,399.496,402.373,406.109,410.233,413.969,417.314,421.05,423.067,425.875,428.751,432.876,437.0,440.736,446.878,451.002,455.127,458.004,460.852,464.117,467.382,469.399,471.416,474.23,477.495,481.231,484.108,487.373,489.39,493.514,497.639,503.781,507.517,509.534,512.381,517.746,520.622,523.887,528.012,530.862,537.003,539.409,543.534,545.551,549.287,552.164,555.9,560.024,563.76,567.884,569.9010000000001,572.754,578.978,582.243,585.979" y="369.466" svg_rhmargin="590.103" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head</text>
  <text x="361.59,367.731,370.997,374.262,378.387,380.921,384.656,388.781,391.658,395.394,397.927,402.052,406.176,410.3,414.425,416.442,420.567,424.691,428.815,430.833,434.957,439.082" y="378.48" svg_rhmargin="443.206" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Neck Surg 2001;127:780</text>
  <text x="443.227" y="378.48" svg_rhmargin="446.963" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="446.969,451.094" y="378.48" svg_rhmargin="453.111" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="345.206,347.612,351.736,355.861,358.267,361.59,366.954,370.69,374.426,378.162,380.013,387.485,389.502,391.351,398.823,402.559,406.683,410.419,412.326,417.227,419.24399999999997,421.056,426.421,430.545,434.281,436.759,439.635,443.76,447.884,451.62,453.425,458.327,460.344,462.212,465.477,467.883,469.752,473.488,475.505,477.522,479.389,484.754,488.49,491.366,494.632,498.756,500.773,504.509,507.386,509.264,512.529,516.653,520.778,524.902,527.308,531.432,534.698,536.715,538.732,542.468,544.485,546.394,550.13,553.007,557.131,562.884,565.29,569.415,571.28,573.686,577.422,580.688,583.093,587.218" y="387.437" svg_rhmargin="590.095" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[58] Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growth factor</text>
  <text x="361.59,364.855,368.98,373.104,375.981,379.246,382.123,384.999,387.1,391.224,395.349,400.592,402.61,406.735,412.044,416.169,420.293,422.699,425.576,428.841,432.577,435.06,438.325,442.45,447.702,451.826,454.703,457.109,460.374,464.499,467.375,471.111,473.988,477.253,481.377,487.61,491.346,496.624,498.642,501.519,506.828,510.954,513.83,517.095,521.22,523.237,526.503,528.908,530.926,534.662,537.927,543.224,547.348,549.7539999999999,555.073,559.197,563.321,565.339,571.481,575.605,579.73,583.465,586.342" y="396.394" svg_rhmargin="590.078" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">expression in untreated osteosarcoma is predictive of pulmonary</text>
  <text x="361.59,367.732,370.997,373.403,377.139,380.016,382.508,386.244,389.121,391.138,394.015,396.51,400.246,404.371,408.496,410.966,415.091,419.215,423.339,426.216,428.766,432.891,435.768,439.892,443.628,447.753,451.877,454.754,456.771,459.648,461.665,464.197,469.561,471.579,473.596,477.721,480.24,485.605,489.341,493.465,496.73,499.996,502.873,505.41,510.774,514.039,516.9159999999999,519.412,523.536,527.661,531.785,535.91,537.927,542.051,544.069,548.266,552.391" y="405.351" svg_rhmargin="556.515" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">metastasis and poor prognosis. Clin Cancer Res 2000;6:572</text>
  <text x="556.5" y="405.351" svg_rhmargin="560.236" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="560.242,564.366" y="405.351" svg_rhmargin="566.383" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="345.207,347.613,351.737,355.862,358.26800000000003,361.59,369.062,372.798,375.204,377.61,380.875,383.752,387.877,391.068,393.945,395.962,399.118,404.483,408.607,412.732,418.874,422.609,426.345,428.362,431.543,436.908,438.925,442.031,447.396,451.52,453.537,459.679,462.836,470.309,472.326,475.478,480.844,483.72,486.597,490.722,493.987,496.004,499.74,502.236,504.253,508.377,512.502,515.615,519.739,522.145,525.309,529.044,532.78,535.657,538.922,543.047,545.064,548.8,551.6769999999999,554.843,558.108,562.233,566.357,570.482,572.888,577.012,580.277,582.295,584.312,588.048" y="414.308" svg_rhmargin="590.065" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[59] Mattern J, Koomagi R, Volm M. Association of vascular endothelial</text>
  <text x="361.591,365.327,368.204,372.328,378.081,380.487,384.612,388.462,390.868,394.604,397.869,400.275,404.399,407.276,411.137,414.402,418.527,422.651,425.593,428.858,431.735,434.611,436.629,440.753,444.878,448.722,454.475,456.492,458.898,463.023,466.863,468.88,473.004,475.41,478.287,482.023,484.429,488.553,494.695,498.819,501.696,505.524,507.541,511.363,517.506,519.523,522.788,525.665,529.789,533.525,536.79,539.667,542.544,545.809,547.826,551.726,555.85,559.116,563.24,566.117,568.134,570.54,574.276,578.143,581.879,586.004" y="423.266" svg_rhmargin="590.128" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">growth factor expression with intratumoral microvessel density and</text>
  <text x="361.591,363.997,368.121,374.263,378.388,382.512,385.389,388.745,392.01,395.275,397.293,399.31,402.634,406.758,409.635,413.759,415.776,417.794,420.2,423.465,426.342,430.077,432.483,434.501,438.625,442.75,446.113,448.131,452.256,455.581,459.705,463.83,469.972,473.707,477.832,481.148,484.413,488.537,490.555,494.679,497.944,500.821,506.963,511.087,513.105,517.23,520.603,522.62,526.745,530.869,534.605,537.893,541.158,544.894,547.771,551.036,553.054,557.178,561.302,567.444,571.18,573.197,576.555,581.068,583.9449999999999,587.269" y="432.223" svg_rhmargin="590.146" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">tumour cell proliferation in human epidermoid lung carcinoma. Br J</text>
  <text x="361.591,366.956,370.692,374.816,378.081,381.346,384.223,386.76,390.885,395.009,399.134,403.258,405.276,409.4,413.524,415.614,419.739,423.863" y="441.237" svg_rhmargin="427.987" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cancer 1996;73:931</text>
  <text x="427.978" y="441.237" svg_rhmargin="431.714" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="431.72,435.844" y="441.237" svg_rhmargin="437.861" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">4.</text>
  <text x="345.207,347.613,351.737,355.862,358.26800000000003,361.59,366.955,370.691,374.427,378.551,380.957,385.082,388.818,392.656,398.02,400.037,403.767,407.503,409.909,413.174,416.439,420.564,424.402,428.915,430.932,434.663,438.399,441.664,444.541,447.806,451.613,455.349,458.225,462.35,466.125,469.861,471.878,475.649,480.162,484.287,488.411,491.288,494.553,497.43,500.306,502.324,506.448,510.573,514.368,518.492,520.8979999999999,524.685,528.421,532.157,535.034,538.299,542.424,544.441,548.177,551.054,554.844,558.109,562.234,566.358,570.482,572.888,577.013,580.278,582.295,584.313,588.049" y="450.194" svg_rhmargin="590.066" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[60] Kvantna A, Steen B, Seregard S. Expression of vascular endothelial</text>
  <text x="361.591,365.327,368.204,372.328,378.081,380.487,384.612,388.518,390.924,394.66,397.925,400.331,404.455,407.332,411.193,413.599,418.964,423.477,429.23,433.355,435.761,439.651,441.668,445.793,449.686,452.562,455.828,458.233,460.251,464.375,468.5,472.624,474.641,478.377,481.254,483.66,487.784,493.926,497.662,501.612,505.737,509.861,512.2669999999999,516.125,520.249,524.374,526.78,530.637,532.655,536.78,540.615,544.74,548.864,551.741,554.147,557.412,560.289,562.306,566.521,569.3979999999999,573.211,577.335,581.071,584.337,588.072" y="459.151" svg_rhmargin="590.089" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">growth factor (VEGF) in retinoblastoma but not in posterior uveal</text>
  <text x="361.591,367.733,370.998,373.015,376.751,380.876,385.0,391.142,394.878,396.895,399.459,403.972,408.096,412.221,414.708,419.221,422.957,426.222,428.767,434.132,437.398,440.27500000000003,442.77,446.894,451.019,455.143,459.267,461.285,465.409,469.534,471.624,475.748,479.872" y="468.108" svg_rhmargin="483.996" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">melanoma. Exp Eye Res 1996;63:511</text>
  <text x="483.99" y="468.108" svg_rhmargin="487.726" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="487.732,491.857" y="468.108" svg_rhmargin="493.874" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="345.207,347.613,351.737,355.862,358.26800000000003,361.59,367.814,371.079,373.956,380.098,383.834,387.958,390.835,393.789,397.914,402.039,403.597,411.068,413.085,414.708,420.85,422.867,425.744,428.15,431.415,434.29200000000003,435.909,443.381,445.39799999999997,446.964,451.477,454.742,457.148,460.024,464.149,468.273,470.291,472.697,475.962,477.576,482.94,484.957,486.533,489.798,492.204,493.789,497.525,499.543,501.56,503.143,507.657,511.782,515.906,520.094,522.5,526.624,529.89,531.907,533.924,537.66,539.677,541.295,544.56,547.826,549.843,551.86,553.427,557.551,561.287,565.411,568.677,571.553,575.678,577.695,581.431,584.308,586.419" y="477.065" svg_rhmargin="590.155" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[61] Hermansson M, Nistér M, Betsholtz C, et al. Endothelial cell hyperplasia</text>
  <text x="361.591,363.608,367.733,371.342,375.466,379.591,385.797,389.533,393.658,397.249,400.985,403.002,405.019,409.144,413.268,415.286,419.021,421.898,424.304,428.428,434.57,438.306,440.323,444.016,447.281,451.406,453.812,457.077,461.201,465.326,468.202,471.467,474.344,477.221,479.238,483.363,487.488,491.124,495.249,497.65500000000003,501.272,507.413,512.778,518.92,524.285,527.972,530.378,534.503,537.38,540.954,545.079,547.096,550.832,553.238,556.503,558.521,561.873,564.279,566.685,570.809,574.074,576.951,578.968,582.704,585.969" y="486.023" svg_rhmargin="590.093" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in human glioblastoma: co-expression of mRNA for platelet-derived</text>
  <text x="361.591,365.327,368.204,372.328,378.081,380.487,384.612,387.555,389.961,393.697,396.962,399.368,403.492,406.369,409.323,411.729,415.853,421.607,427.36,431.484,433.89,436.874,441.387,444.301,447.566,451.69,455.426,457.444,461.569,464.482,468.218,472.342,476.467,479.391,483.516,489.269,495.094,499.219,502.123,505.0,508.265,511.53,514.796,518.92,521.326,525.451,528.328,531.261,534.138,538.262,541.998,545.734,548.999,551.952,554.358,557.2349999999999,560.116,563.852,567.976,570.382,574.572,577.837,580.714,582.731,586.855" y="495.037" svg_rhmargin="590.12" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">growth factor (PDGF) B chain and PDGF receptor suggests autocrine</text>
  <text x="361.591,365.327,368.204,372.328,378.081,380.487,384.612,387.157,390.034,392.44,394.457,400.599,404.723,406.741,410.477,412.883,414.9,419.024,423.149,425.166,427.746,431.87,434.747,438.871,442.13599999999997,444.639,450.78,454.516,456.922,458.939,461.475,466.839,470.105,473.841,477.966,480.466,484.202,487.467,489.484,491.974,497.339,499.854,503.59,506.09,511.455,513.971,518.095,522.22,526.344,530.469,532.486,536.61,540.735,542.752,546.877,551.001,555.126" y="503.994" svg_rhmargin="559.25" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">growth stimulation. Proc Natl Acad Sci U S A 1988;85:7748</text>
  <text x="559.334" y="503.994" svg_rhmargin="563.07" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="563.076,567.201,571.327" y="503.994" svg_rhmargin="573.344" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">52.</text>
  <text x="345.207,347.613,351.737,355.862,358.26800000000003,361.59,366.103,369.368,373.104,375.122,377.528,382.041,385.306,389.042,391.05899999999997,394.753,400.118,402.135,405.751,409.875,411.893,416.017,418.894,422.159,425.036,427.441,432.806,436.931,438.948,443.073,446.737,454.208,456.225,459.888,467.36,470.625,474.75,476.767,480.892,484.628,487.034,490.769,494.505,498.63,501.506,505.631,509.756,513.459,518.824,520.841,524.457,527.722,530.1279999999999,533.754,537.49,539.507,541.524,545.148,550.513,554.162,560.305,564.429,566.447,568.853,570.87,574.135,577.401,581.525,583.931,586.808" y="512.951" svg_rhmargin="590.073" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[62] Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multicentre</text>
  <text x="361.591,364.468,367.733,371.857,375.982,378.858,381.264,385.344,387.75,390.626,394.751,400.893,405.016,407.421,411.546,414.811,418.905,426.377,429.642,433.766,435.784,439.049,442.785,446.91,450.99,456.355,459.62,462.026,464.043,468.168,472.292,476.417,478.434,482.17,485.047,487.453,491.577,497.719,501.455,505.581,511.335,514.211,518.336,522.46,526.585,528.6020000000001,532.735,537.248,540.125,544.187,547.064,551.103,557.246,561.37,565.495,567.901,572.025,575.761,577.778,583.92,588.045" y="521.908" svg_rhmargin="590.062" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">report from the Mexican Retinoblastoma Group. Br J Ophthalmol</text>
  <text x="361.591,365.715,369.84,373.964,378.089,380.106,384.23,388.355,390.445,394.569,398.694,402.818" y="530.865" svg_rhmargin="406.942" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2004;88:1074</text>
  <text x="406.945" y="530.865" svg_rhmargin="410.681" style="fill:#171615;font-family:LFHPIO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="410.687,414.812" y="530.865" svg_rhmargin="416.829" style="fill:#171615;font-family:LFHPIM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="85.039,92.26,96.492,99.099,103.164,105.483,108.17,112.235,113.645,115.797,118.431,124.982,129.047,133.606,135.017,139.081,140.492,144.724,148.789,151.368,153.273,157.673,162.072,166.472,170.871,172.776,175.405,179.804,184.204,186.356,190.755,195.154,517.041,522.931,528.821,534.711,536.863,543.414,547.973,550.874,552.285,556.685,560.917,563.3,567.532,571.597,573.008,575.16,579.224,583.624" y="9.870999999999981" svg_rhmargin="590.176" style="fill:#171615;font-family:LFHPHG+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Wu et al. Medicine (2018) 97:51 www.md-journal.com</text>
  <text x="335.396" y="739.625" svg_rhmargin="339.796" style="fill:#171615;font-family:LFHPOE+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">9</text>
 </g>
</svg>
